Concurrent neoadjuvant endocrine therapy with chemotherapy in HR+HER2- breast cancer: a systematic review and meta-analysis

Overview of attention for article published in Frontiers in endocrinology, February 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 1 X post from an account with 4,897 followers.

New Research: Concurrent neoadjuvant endocrine therapy with chemotherapy in HR+HER2- breast cancer: a systematic review and meta-analysis: The role of simultaneous neoadjuvant endocrine therapy in chemotherapy in HR+HER2- breast… https://t.co/T5O0d0bwuQ #E

28 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.